Your session is about to expire
← Back to Search
Proton Beam Therapy
Proton Therapy for Pediatric Brain Cancer
N/A
Recruiting
Led By Bree R Eaton, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Primary tumor located within the supratentorial brain
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline up to 3 years from treatment
Awards & highlights
Study Summary
This trial studies how well spectroscopic MRI guided proton therapy works in assessing metabolic change in pediatric patients with brain tumors.
Who is the study for?
This trial is for children with high-grade brain tumors (WHO grade 3-4) who are recommended to receive radiation therapy and can undergo MRI scans. It's open to all genders, races, and ethnic groups. The tumor must be in the upper part of the brain. Kids with significant illnesses that make MRI unsafe or have certain implants like pacemakers are not eligible.Check my eligibility
What is being tested?
The study is testing how well a special type of MRI called spectroscopic imaging works alongside proton therapy to see changes in the metabolism of brain tumors in kids without using contrast agents. This non-invasive method could help distinguish between healthy tissue and tumor metabolism.See study design
What are the potential side effects?
Since this trial focuses on assessing metabolic change through imaging rather than treatment effects, side effects may primarily relate to discomfort or risks associated with undergoing MRIs, such as anxiety in closed spaces or reactions if sedation is needed.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My brain tumor is located above the cerebellum.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from baseline up to 3 years from treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline up to 3 years from treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cho/NAA ratios at baseline in tumor and in regions of tumor recurrence in patients receiving standard of care radiotherapy
Feasibility of using sMRI to define proton therapy high dose (60Gy) target volumes for treatment delivery
Incidence of adverse events
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Diagnostic (sMRI)Experimental Treatment2 Interventions
Patients undergo sMRI over less than 1 hour within 7 days prior to start of standard of care radiation therapy and at 10 weeks.
Group II: Group 2Active Control2 Interventions
Patients will undergo 3-4 sMRI scans at baseline prior to RT, 1 month, 4 months, and 7 months after RT, and/or at any time of suspected tumor recurrence.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Magnetic Resonance Spectroscopic Imaging
2012
Completed Phase 1
~430
Proton Therapy
2009
Completed Phase 2
~280
Find a Location
Who is running the clinical trial?
Emory UniversityLead Sponsor
1,639 Previous Clinical Trials
2,560,621 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,664 Previous Clinical Trials
40,926,108 Total Patients Enrolled
Bree R Eaton, MDPrincipal InvestigatorEmory University Hospital/Winship Cancer Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My brain tumor is confirmed or suspected to be high-grade.My brain tumor is non-cancerous and low-grade.My brain tumor is located above the cerebellum.I am advised to undergo definitive radiation therapy.I am eligible regardless of my gender, race, or ethnicity.
Research Study Groups:
This trial has the following groups:- Group 1: Diagnostic (sMRI)
- Group 2: Group 2
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any further applicants accepted for this research endeavor?
"That is accurate. Clinicaltrials.gov contains information that this medical trial, which was initially posted on December 20th 2018, is actively looking for volunteers. 25 individuals across 3 separate sites are required to complete the study."
Answered by AI
How many participants have committed to this medical experiment?
"Affirmative. Data available on clinicaltrials.gov suggests that this research initiative, which was originally posted in December of 2018, is actively searching for participants. A total of 25 patients will be recruited from 3 separate sites."
Answered by AI
Share this study with friends
Copy Link
Messenger